Valentina Rose Garbarino
The University of Texas at San Antonio Health Science Center
Also published as: V.R. Garbarino, Valentina Garbarino, Valentina R. Garbarino
10 papersORCID 0000-0002-0973-7186OpenAlex
Is this you? Claim this profile
Papers
AAIC 2025 Abstract
Head‐to‐head comparison of two senolytic therapies in a mouse model of tauopathy
Experiments in miceSenolytics
Communications Medicine
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial
Non-randomized trial in 10 peopleRapamycin
Neurotherapeutics
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
Non-randomized trial in 5 peopleSenolytics
Nature Medicine
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Non-randomized trial in 5 peopleSenolytics
The Journal of Clinical Investigation
Biological aging processes underlying cognitive decline and neurodegenerative disease
ReviewMechanisms
The Journal of Prevention of Alzheimer's Disease
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial
Study protocolSenolytics
Mechanisms of Ageing and Development
A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials
ReviewInterventions
Frontiers in Neuroscience
Extended Postnatal Brain Development in the Longest-Lived Rodent: Prolonged Maintenance of Neotenous Traits in the Naked Mole-Rat Brain
Experiments in animalsMechanisms
Neurobiology of Aging
Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
Experiments in naked mole-ratsMechanisms
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
NIAP, Transcriptomic Signature for Chronic Stress Contribution to ADRD Risk, NIAP25-1446397, 2025, Jan 1, 2025
Sources: openalex.org